ASX:MVPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Medical Developments International Ltd
$0.490
$0.010 (2.00%)
Day Range
$0.485 – $0.500
52 Week Range
$0.365 – $0.765
Volume
34.18K
Avg Volume (10D)
361.58K
Market Cap
$55.20M
P/E Ratio
595.24
Price Chart
Market Statistics
Open$0.500
Previous Close$0.500
Day High$0.500
Day Low$0.485
52 Week High$0.765
52 Week Low$0.365
Valuation
Market Cap55.20M
Shares Outstanding112.66M
P/E Ratio (Annual)595.24
Price to Book1.03
Trading Activity
Volume34.18K
Value Traded16.78K
Bid$0.480 × 1,059
Ask$0.490 × 1,224
Performance
1 Day4.17%
5 Day13.64%
13 Week12.36%
52 Week-26.47%
YTD-9.91%
Technical Indicators
RSI (14)60.49
50-Day SMA$0.413
200-Day SMA$0.467
Latest News
Biotechnology
Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
Biotechnology
Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]